Publications

5674 Results

Phase II trial of pibenzimol in advanced pancreatic carcinoma. A Southwest Oncology Group study.

Authors
E Kraut;J Neidhart;J Macdonald
Journal / Conference
ASCO 9:130(#504)
Year
1990
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8800

A phase I study of the sequential combination of recombinant gamma-interferon (IFN7) and recombinant interleukin-2 (IL2) in patients with disseminated malignant disease.

Authors
CW Taylor;EM Chase;EM Hersh;JJ Rinehart;RP Whitehead;R Gonzalez;PA Bunn;J Neidhart
Journal / Conference
ASCO 9:192(#742)
Year
1990
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-8801

Prospective correlation of cytotoxic response and DNA content parameters in advanced squamous cell cancer of the head and neck (SCCHN).

Authors
J Ensley;Z Maciorowski;H Pietraszkiewicz;J Kish;E Tapazoglou;J Jacobs;R Mathog;W Sakr;M Al-Sarraf;B Metch;D Schuller;C Coltman, Jr
Journal / Conference
ASCO 9:173(#671)
Year
1990
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8855

Intravenous melphalan and GM-CSF: A phase I study.

Authors
E Poplin;B Redman;H Smith;S Balcerzak;DS Alberts
Journal / Conference
AACR 31:204(#1213)
Year
1990
Research Committee(s)
Developmental Biologics
Study Number(s)
SWOG-8825

Does cisplatin (DDP) - based therapy improve survival in extensive non-small cell lung cancer (NSCLC)? Southwest Oncology Group studies.

Authors
K Albain;J Crowley;M LeBlanc;R Livingston
Journal / Conference
ASCO 9:227(#877)
Year
1990

Evaluation of chemotherapy (CT) in endocrine resistant Studies prostate cancer (ERPC) patients (PTS) with measurable (MD) versus bone disease only (BDO): The Southwest Oncology Experience.

Authors
M Eisenberger;B Blumenstein;P Scardino;ED Crawford
Journal / Conference
ASCO 9:153(#596)
Year
1990

Immunocytochemical evaluation of HER-2/NEU oncogene expression in different evolutionary stages of breast carcinoma and correlation with clinical pathological characteristics.

Authors
DC Allred;R Molina;AK Tandon;SJ Schnitt;CK Osborne;DC Tormey;KW Gilchrist;WL McGuire
Journal / Conference
ASCO 9:23(#83)
Year
1990

HER-2/neu expression identified a group of node negative breast cancer patients at high risk for recurrence.

Authors
D Allred;A Tandom;R Molina;D Tormey;CK Osborne;K Gilchrist;R Gray;E Mansour;M Abeloff;W McGuire
Journal / Conference
ASCO 9:23(#85)
Year
1990

Compliance with protocol: Quality assurance (QA) data from the Southwest Oncology Group (SWOG).

Authors
M Sunderland;S Kuebler;G Weiss;C Coltman, Jr
Journal / Conference
ASCO 9:60(#229)
Year
1990

A new model for estimating S-phase fraction in node-negative breast cancer patients.

Authors
MA Owens;LG Dressler;DC Tormey;CK Osborne;KW Gilchrist;R Gray;E Mansour;M Abeloff;WL McGuire
Journal / Conference
AACR 31:184(#1094)
Year
1990